The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of nivolumab (Nivo) + nab-paclitaxel (nab-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).
 
Zev A. Wainberg
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Five Prime Therapeutics; Genentech; Lilly; Merck; Merck KGaA; Novartis; Sirtex Medical
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Edward Jae-Hoon Kim
Honoraria - ARMO BioSciences; Vicus Therapeutics
Consulting or Advisory Role - ARMO BioSciences; Vicus Therapeutics
Research Funding - Boston Biomedical (Inst); Celgene (Inst); EpicentRx (Inst); Halozyme (Inst); Merck (Inst); OncoMed (Inst)
 
Ben George
Honoraria - Newlink Genetics
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Cook Medical; Exelixis; Foundation Medicine; Ipsen; Merrimack; Taiho Pharmaceutical; TERUMO
Research Funding - Boehringer Ingelheim (Inst); CeGaT (Inst); Celgene (Inst); Eisai (Inst); Foundation Medicine (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst)
 
Aparna Kalyan
Honoraria - Samumed
Research Funding - Bristol-Myers Squibb (Inst)
 
E. Gabriela Chiorean
Consulting or Advisory Role - AstraZeneca; Celgene; Exelixis; Five Prime Therapeutics; Genentech/Roche; Halozyme; Ipsen; Vicus Therapeutics
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Genentech/Roche
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; AZTherapies; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Honoraria - Esanex
Consulting or Advisory Role - Lilly
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck
Research Funding - Acerta Pharma; Bayer; Bristol-Myers Squibb; Celgene; Checkpoint Sciences; Eisai; EMD Serono; Esanex; Genentech; Incyte; Infinite Biomedical; Lilly; MedImmune; Merck; Mirati Therapeutics; Modern Biosciences; Regeneron; Sanofi; Seagen; Silence Therapeutics; Spectra Laboratories; Tesaro
 
Aparna Raj Parikh
Employment - Genentech
 
Rishi Jain
No Relationships to Disclose
 
Daniel R. Carrizosa
Research Funding - Aeglea Biotherapeutics (Inst); ARIAD/Takeda (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst)
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly
 
Rafia Bhore
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Sibabrata Banerjee
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Celgene; Celgene (I); Novartis; Novartis (I)
Stock and Other Ownership Interests - Celgene
 
Larry Lyons
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Chrystal Ursula Louis
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Cell Medica
 
Teng Jin Ong
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Peter J. O'Dwyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Amgen; Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics